Title : Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.

Pub. Date : 2014 Oct 27

PMID : 25073034






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Erlotinib is an orally administered tyrosine kinase inhibitor used in clinical oncology to inhibit EGF signaling. Erlotinib Hydrochloride epidermal growth factor like 1 Rattus norvegicus
2 Late posttransplant EGF and EGF receptor levels were reduced with erlotinib. Erlotinib Hydrochloride epidermal growth factor like 1 Rattus norvegicus
3 Late posttransplant EGF and EGF receptor levels were reduced with erlotinib. Erlotinib Hydrochloride epidermal growth factor like 1 Rattus norvegicus
4 Therefore, EGF blocking by erlotinib provides a novel pathway to prevent chronic allograft injury. Erlotinib Hydrochloride epidermal growth factor like 1 Rattus norvegicus